PARK7 protects pancreatic beta-cells from oxidative stress conditions, and its deficiency is associated with decreased inflammatory and adipogenesis responses [141–143] and type 2 diabetes [144, 145]. Here, PARK7 is linked to type 2 diabetes mellitus.